Analysis reveals many ED visits 'virtually indistinguishable' as urgent or nonurgent

A study published by JAMA Internal Medicine found half of the visits to the ED for the top 10 diagnoses are indistinguishable from being urgent or nonurgent.

The purpose of triage in the ED is to prioritize patients who need immediate and urgent care and those who have a nonurgent condition. “We sought to determine whether a triage determination of nonurgent status in the [ED] effectively ruled out the possibility of serious pathologic conditions, as indicated by visits resulting in diagnostic screening, procedures, hospitalization, or death, and compared these findings with visits deemed as urgent from triage,” wrote Renee Y. Hsia, MD, MSc, of the University of California-San Francisco, and colleagues.

The study collected data from the National Hospital Ambulatory Medical Care Survey containing triage scores for ED visits from a triage nurse, based on a scale of 1 to 5, with 1 being immediate and 5 nonurgent. Methodology included focusing on nonelderly adults aged 18 to 64 years and comparing the outcomes of visitslabeled nonurgent with that of visits labeled as urgent between January 1, 2009, to December 31, 2011.

Out of a total of 240 million visits, 218.49 million visits (92.5 percent) were deemed urgent at triage and 17.76 million visits (7.5 percent) as nonurgent. A total of 33.82 million visits (15.5 percent) of those labeled as “urgent” arrived by ambulance, compared with 1.19 million visits (6.7 percent) considered nonurgent. Of the nonurgent visits, a total of 776,000 visits resulted in admissions and of these, 126,000 were admissions to critical care units. A total of 27.86 million urgent visits resulted in admissions, of which only 2.91 million were admissions to critical care units. Overall, a total of 1.01 million nonurgent visits resulted in admission, compared with 32.49 million urgent visits.

After analyzing a nearly 60,000 observation sample, the authors found that for nonurgent visits the study, six of the top 10 reasons—back symptoms, abdominal pain, sore throat, headache, chest pain, and low back pain—were also in the top 10 symptoms found at urgent visits. They also found that five (backache, lumbago, acute upper respiratory infection, cellulitis, and acute pharyngitis) of the top 10 diagnoses for nonurgent patients were identical to the those of urgent patients.

“Our findings indicate that either patients or health care professionals do entertain a degree of uncertainty that requires further evaluation before diagnosis,” concluded Hsia and colleagues. “Half of the top 10 diagnoses, among over 14,000 International Classification of Diseases, Ninth Revision codes, are found in both nonurgent and urgent visits shows that 50 percent of these visits are virtually indistinguishable from each other.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.